Jinee Baruah

Maternal antenatal profile and immediate neonatal outcome in VLBW and ELBW babies

ObjectiveTo evaluate the antenatal profile of the mother and the immediate neonatal morbidity and mortality till discharge.MethodsThe study was a retrospective analysis of 92 patients of preterm labour who delivered babies weighing <1500 gms at 26 weeks to 34 weeks of gestation. The maternal demographic profile, causes of preterm labour, treatment profile and delivery outcome were recorded. Similarly the immediate neonatal morbidity and mortality were recorded in our case file. Both these data of maternal and neonatal profile were pooled and analysed.ResultsA total of 92 mothers in preterm labour at 26 to 34 weeks were admitted and subsequently delivered 70 VLBW babies (<1500 gms) and 36 ELBW babies (<1000 gms) including 8 pairs of twins and 3 triplets pregnancies. Majority of the patients (93.4%) were booked. Amongst the various high risk factors for preterm labour, anaemia, during pregnancy (32.6%), bacterial vaginosis (26%), gestational hypertension (18.4%) and pervious history of preterm labour (18.4%) were common associations. Calcium channel blocker (Depin) tocolysis was effective in postponing labour, from 48 hours to more than 2 weeks. The cesarean section rate was very high (67.3%) in our study. The commoner neonatal complications in both VLBW and ELBW babies were RDS, neonatal jaundice and sepsis. Features of IUGR were seen in both the groups (22.8% in VLBW and 22.2% in ELBW babies). The neonatal mortality rate till discharge was 15.7% in VLBW group and 33.3% in ELBW group. The morality rate was highest in 26 to 30 weeks gestation babies and in babies weighing <800 gms.ConclusionAntenatal profile of preterm labour in our series showed a number of high risk factors. The identification of common high risk factors is important for appropriate prenatal care. A better neonatal survival rate was possible due to timely intervention, appropriate management and NICU care facility available in our tertiary care centre.

A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome

OBJECTIVES: To compare the efficacy of letrozole and clomiphene citrate (CC) in patients of anovulatory polycystic ovarian syndrome (PCOS) with infertility. MATERIALS AND METHODS: This prospective randomized clinical trial included 204 patients of PCOS. 98 patients (294 cycles) received 2.5–5 mg of letrozole; 106 patients (318 cycles) received 50–100 mg of CC (both orally from Days 3–7 of menstrual cycle). The treatment continued for three cycles in both the groups. Main outcome measures: ovulation rate, endometrial thickness, and pregnancy rate. Statistical analysis was done using SPSS 13 software. P value less than 0.05 was considered significant. RESULTS: The mean number of dominant follicles in letrozole groups and CC groups was 1.86±0.26 and 1.92±0.17, respectively (P=0.126). Number of ovulatory cycle in letrozole group was 196 (66.6%) versus 216 (67.9%) in CC group (P=0.712). The mean mid-cycle endometrial thickness was 9.1±0.3 mm in letrozole group and 6.3±1.1 in CC group, which was statistically significant (P=0.014). The mean Estradiol [E2] level in clomiphene citrate group was significantly higher in CC group (364.2±71.4 pg/mL) than letrozole group (248.2± 42.2 pg/mL). 43 patients from the letrozole group (43.8%) and 28 patients from the CC group (26.4%) became pregnant. CONCLUSION: Letrozole and CC have comparable ovulation rate. The effect of letrozole showed a better endometrial response and pregnancy rate compared with CC.

Cesarean section for suspected fetal distress, continuous fetal heart monitoring and decision to delivery time

ObjectiveTo find out the efficacy of continuous fetal heart monitoring by analyzing the cases of cesarean section for nonreassuring fetal heart in labor, detected by cardiotocography (CTG) and correlating these cases with perinatal outcome. To evaluate whether a 30 minute decision to delivery (D-D) interval for emergency cesarean section influences perinatal outcome.MethodsThis was a prospective observational study of 217 patients who underwent cesarean section at ≥ 36 weeks for non-reassuring fetal heart in labor detected by CTG. The maternal demographic profile, specific types of abnormal fetal heart rate tracing and the decision to delivery time interval were noted. The adverse immediate neonatal outcomes in terms of Apgar score <7 at 5 minutes, umbilical cord þH <7.10, neonates requiring immediate ventilation and NICU admissions were recorded. The correlation between non-reassuring fetal heart, decision to delivery interval and neonatal outcome were analyzed.ResultsOut of 3148 patients delivered at ≥ 36 weeks, 217 (6.8%) patients underwent cesarean section during labor primarily for non-reassuring fetal heart. The most common fetal heart abnormality was persistent bradycardia in 106 (48.8%) cases followed by late deceleration in 38 (17.5%) cases and decreased beat to beat variability in 17 (7.8%) cases. In 33 (15.2%) babies the 5 minutes Apgar score was <7 out of which 13 (5.9%) babies had cord þH <7.10. Thirty three (15.2%) babies required NICU admission for suspected birth asphyxia. Rest 184 (84.7%) neonates were born healthy and cared for by mother. Regarding decision to delivery interval of ≤30 minutes versus >30 minutes, there was no significant difference in the incidence of Apgar score <7 at 5 minutes, cord pH <7.10 and new born babies requiring immediate ventilation. But the need for admission to NICU in the group of D-D interval ≤ 30 minutes was significantly higher compared to the other group where D-D interval was >30 minutes.ConclusionNon-reassuring fetal heart rate detected by CTG did not correlate well with adverse neonatal outcome. There was no significant difference in immediate adverse neonatal outcome whether the D-D time interval was ≤ 30 minutes or >30 minutes; contrary to this, NICU admission for suspected birth asphyxia in ≤ 30 minutes group was significantly higher.

A rare case of primary malignant melanoma of cervix

Primary malignant melanoma (MM) of the uterine cervix is a rare neoplasm. Historically all MMs of the cervix were thought to be metastatic. But after the discovery of melanocytes in the cervix in 1959, it was recognized that primary MM of the cervix exists as a separate entity. The treatment of this condition is not yet standardized and the overall prognosis of these patients is very poor. We present a 40-year-old patient of primary MM of cervix including its diagnosis, management, follow-up and a brief review of literature.

Angiokeratoma of vulva with coexisting human papilloma virus infection: a case report

We report a 25-year-old unmarried girl who developed multiple papular lesions on both labia majora with the past history of documented HPV-6 viral infection in the vulva. A wide local excision was performed and histopathological report confirmed a case of angiokeratoma. To the best of our knowledge this is the first case of angiokeratoma of vulva following chronic HPV infection.

Successful pregnancy outcome after urinary diversion.

Ain RJ, Vance MB. 2005. Epidural haematoma after epidural steroid injection in a patient withholding enoxaparin per guidelines. Anaesthesiology 102:701–703. Beilin Y, Abramovitz S. 2007. The anticoagulated parturient. International Anesthesiology Clinics 45:71–81. Coppell JA, Thalheimer U, Zambruni A, et al. 2006. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. Blood Coagulation and Fibrinolysis 17:97–104. Favaloro EJ, Bonar R, Aboud M, et al. 2005. How useful is the monitoring of (low molecular weight) heparin therapy by antiXa assay? A laboratory perspective. Lab Hematol 11:157–162. Forsnes E, Occhino A, Acosta R. 2009. Spontaneous spinal epidural haematoma in pregnancy associated with using low molecular weight heparin. Obstetrics and Gynecology 113:532–533. Harding SA, Mallett SV, Peachey TD, et al. 1997. Use of heparinase modified thrombelastography in liver transplantation. British Journal of Anaesthesia 78:175–179. Horlocker TT, Wedel DJ, Benzon H, et al. 2003. Regional anaesthesia in the anticoagulated patient: defining the risks. Regional Anesthesia and Pain Medicine 28:172–197. Horlocker TT, Wedel DJ. 1998. Neuraxial block and lowmolecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Regional Anesthesia and Pain Medicine 23:164–177. Kenny B, Volobuev V. 2007. Splenic rupture following elective caesarean delivery at term, complicated by low-molecularweight heparin use. Australian and New Zealand Journal of Obstetrics and Gynaecology 47:514–516. Ma JM, Jackevicius CA, Yeo E. 2004. Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease. Annals of Pharmacotherapy 38:1576–1581. Maslovitz S, Many A, Landsberg JA, et al. 2005. The safety of low molecular weight heparin therapy during labour. Journal of Maternal-Fetal and Neonatal Medicine 17:39–43. Orlikowski CE, Rocke DA, Murray WB, et al. 1996. Thrombelastography changes in preeclampsia and eclampsia. British Journal of Anaesthesia 77:157–161. Vandermeulen EP, Van Aken H, Vermylen J. 1994. Anticoagulants and spinal-epidural anaesthesia. Anesthesia and Analgesia 79:1165–1177. Wysowski DK, Talarico L, Bacsanyi J, et al. 1998. Spinal and epidural haematoma and low-molecular-weight heparin. New England Journal of Medicine 338:1774–1775.